Crossmark

Efficacy and Safety of Fractional CO2 Laser Combined with Halometasone Cream for Treatment of Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial

Crossref DOI link: https://doi.org/10.1007/s13555-023-00944-w

Published Online: 2023-06-24

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Gongfeng

Chang, Yuan

Wu, Haixuan

Liang, Xuelei

Liu, Yi

Zhuo, Fenglin https://orcid.org/0000-0001-8972-5080
Clinical Trials ^BETA

Clinical trials referenced in this document:

chictr210001948 at Chinese Clinical Trial Registry

Documents that mention this clinical trial

Efficacy and Safety of Fractional CO2 Laser Combined with Halometasone Cream for Treatment of Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial
https://doi.org/10.1007/s13555-023-00944-w
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82273555)

Natural Science Foundation of Beijing Municipality (7222040)
License Information

Text and Data Mining valid from 2023-06-24

Version of Record valid from 2023-06-24
More Information

Article History

Received: 28 March 2023

Accepted: 19 May 2023

First Online: 24 June 2023

Document is current

Any future updates will be listed below